Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13.
Serum Biomarker gMS-Classifier2: Predicting Conversion to Clinically Definite Multiple Sclerosis.
Diagnosing neuromyelitis optica.
Flow Cytometric Assay Detecting Cytotoxicity against Human Endogenous Retrovirus Antigens Expressed on Cultured Multiple Sclerosis Cells.
Neuromuscular adaptations to long-term progressive resistance training translates to improved functional capacity for people with multiple sclerosis and is maintained at follow-up.
Symptoms and Association with Health Outcomes in Relapsing-Remitting Multiple Sclerosis: Results of a US Patient Survey.
11C-Acetate PET Imaging in Patients with Multiple Sclerosis.
Profile of Differential Promoter Activity by Nucleotide Substitution at GWAS Signals For Multiple Sclerosis.
The possible efficacy of artichoke in fluconazole related hepatotoxicity.
Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study.
Health related quality of life in patients recently diagnosed with multiple sclerosis.
[Acute disseminated encephalomyelitis (ADEM): its diagnostic criteria and therapy].
Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool.
Longitudinally extensive varicella-zoster virus myelitis in a multiple sclerosis patient.
Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: Implications for remyelination at lesions sites.
Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis
Fast facts: multiple sclerosis.
FDA Drug Safety Communication: FDA warns about cases of rare brain infection with MS drug Gilenya (fingolimod) in two patients with no prior exposure to immunosuppressant drugs
Adolescent-onset Krabbe disease with an initial diagnosis of multiple sclerosis and a novel mutation.
Biogen Reports Top-Line Results from Phase 3 Study Evaluating Natalizumab in Secondary Progressive MS
Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
Aquaporin-4 mediates communication between astrocyte and microglia: Implications of neuroinflammation in experimental Parkinson's disease.
Multiple sclerosis-like neurological manifestations in a coeliac patient: nothing is as it seems.
Microsomal prostaglandin E synthase-1 aggravates inflammation and demyelination in a mouse model of multiple sclerosis.
Vitamin D as a clinical biomarker in multiple sclerosis.

Pages